Freshpet, Inc. Overview
Freshpet, Inc. is a single-brand, single-segment manufacturer and marketer of fresh, refrigerated food and treats for dogs and cats, distributed in the United States, Canada and Europe primarily through a proprietary network of company-owned branded refrigerators ("Freshpet Fridges") installed in third-party retail stores. The company is a Delaware corporation with its principal executive offices in Bedminster, New Jersey.
Employee trend (headcount at fiscal year end)
FY2023 and FY2024 headcounts were disclosed in the respective annual reports but were not verified from primary sources in this review and are therefore shown as nd rather than estimated.
Positioning statement (≈150 words). Freshpet occupies a structurally unusual position in packaged food: it is a sub-scale player by revenue in an oligopolistic category, yet it is the effective owner of a distribution format it invented. By financing, installing and maintaining roughly 30,700 branded refrigerators inside blue-chip grocery, mass, club and pet-specialty retailers, Freshpet has converted merchandising real estate into a quasi-proprietary channel that competitors cannot rent. That asset, combined with the only at-scale fresh refrigerated pet-food manufacturing network in North America (three kitchen complexes, ~99% of volume on Freshpet-owned equipment), constitutes the company's moat. The business crossed $1bn of net sales in 2025, turned free-cash-flow positive a year ahead of plan, and released its deferred tax valuation allowance — three milestones that mark the transition from a capital-consuming growth story to a self-funding compounder. The open questions are category growth durability, the response of Purina, Mars, Hill's, General Mills and well-funded DTC entrants, and whether ~4% share of the US dog-food category can become a double-digit share.
2.1 The company's own description
The FY2025 Form 10-K opens with the company's positioning verbatim in substance: Freshpet describes itself as disrupting the over $56.0 billion United States pet food industry by driving consumers to reassess conventional dog and cat food offerings that it says have remained essentially unchanged for decades. It positions the brand to benefit from mainstream trends of pet humanisation and consumer focus on health and wellness, prices products to be accessible to the average consumer, and sells across grocery, mass, international, digital, pet specialty and club classes of retail. The mission is stated as elevating the way pets are fed with fresh food that nourishes all, executed in ways that are good for "Pets, People, and Planet." As of 31 December 2025 US household penetration was approximately 15.2 million households.
2.2 Independent characterisation of the business model
Freshpet is best understood as three businesses stapled together, each of which carries a distinct economic signature.
A branded fresh-food manufacturer. Freshpet owns and operates what it believes to be the first fresh, refrigerated pet food manufacturing network in North America. Products are cooked in small batches at lower temperatures than kibble extrusion, contain no preservatives or additives, and are held under refrigeration from production to point of sale. In 2025 approximately 99.1% of product volume was manufactured on Freshpet-owned equipment — an unusually high degree of vertical control for a company of this size, and the source of both its gross-margin trajectory and its capital intensity. All products are made in the United States other than select products produced in the European Union for European customers.
A refrigeration infrastructure operator. Freshpet designs, buys, installs, maintains, audits and ultimately owns the fridges in which its product sits. Fridges are typically four feet wide by seven feet high, replacing standard pet-aisle shelving or occupying an end-cap. The current fleet spans over 2.1 million cubic feet of refrigerated retail space. The company estimates a cash-on-cash payback of under twelve months on the average fridge installation. Fridges purchased in 2025 carry a five-year manufacturer warranty (previously three years); less than 0.5% of the network is out of service at any time. This is a capital-expenditure line item that behaves economically like customer-acquisition spend with a hard asset attached, and it is the principal reason capital expenditure ran at $148m–$239m per year across FY2023–FY2025 against revenue of $767m–$1,102m.
A consumer marketing organisation. Fresh pet food requires converting a consumer away from a habit, not switching a SKU. Freshpet therefore runs national television, streaming, digital, social and retail-media campaigns; media spend rose $29.2m in FY2025 alone. The fridge fleet doubles as a permanent in-store advertising asset in ~30,235 locations.
2.3 Revenue model
Revenue is essentially 100% product sales of physical goods, recorded net of discounts, returns and promotional allowances. There is no meaningful service, licensing or subscription revenue at consolidated scale; the company operates a direct-to-consumer offering ("meal plans customised for your pet, fresh to your door") but does not disclose it as a separate revenue line. Sales are made either directly to retailers or through third-party distributors, at the retailer's election.
2.4 Value chain position and customers
Freshpet sits between agricultural protein and produce suppliers upstream and large concentrated retailers downstream, and has integrated forward into refrigerated merchandising and backward into manufacturing. It relies on third-party asset-based refrigerated carriers for outbound freight from its Pennsylvania and Texas distribution centres, on co-packers for certain products, and on national and regional distributors for certain retailers.
Customer concentration is high and rising in importance:
End-markets served are US, Canadian and European retail pet food and treats, split by class of trade into grocery, mass, international, digital, pet specialty and club. In the United Kingdom the company does business with four retailers across approximately 637 stores.
Strategy
10.1 Stated strategy — themes from the FY2025 Form 10-K and the 2026 proxy
The strategy as articulated by management rests on five explicit pillars.
Mainstream fresh. The company's framing is that Freshpet has "an opportunity to capture market share in this large and growing category by mainstreaming fresh food for pets and making fresh food a greater part of dogs' and cats' main meals." The strategic distinction Freshpet draws against DTC fresh brands is accessibility: products are "priced to be accessible to the average consumer, providing us with broad demographic appeal."
Distribution expansion. Growth depends on "partnering with customers to secure space for our Freshpet Fridges" and on increasing multi-fridge penetration, which stood at 24% of stores at FY2025 and 25% by mid-2026. Management has described 2025 as its best year in over a decade for new-store expansion despite intensifying competition.
Velocity per fridge. Increasing sales velocity from the average Freshpet Fridge through awareness, trial, adoption and innovation, supported by marketing investment.
Capacity with capital discipline. Building capacity to meet demand through the timely expansion of the Freshpet Kitchens, but now explicitly subject to a capital-efficiency framework. The March 2026 investor presentation frames the objective as "disciplined capital spending; applying capital efficiency framework with scale benefits."
Manufacturing as competitive advantage. The CEO's Q2 2026 formulation is the clearest statement of the thesis: manufacturing scale enables the company "to create the highest quality products at the lowest cost."
10.2 Announced strategic initiatives, last 24 months
10.3 Management's financial targets
Guidance revision history — a useful credibility record:
The 2025 sequence is three consecutive downgrades; the 2026 sequence is two consecutive upgrades. The 2027 $1.8bn net sales target was withdrawn in August 2025 and has not been reinstated — only a relative growth commitment remains at the top line, while both margin targets have been retained and one has been raised.
Products & Services
All products sit within the single reporting segment and are sold under the master Freshpet brand, with sub-brands, ingredients, packaging and labelling customised by class of trade. Every recipe is complete-and-balanced to AAFCO nutrient profiles for the stated life stage. The core physical formats are slice-and-serve rolls, bagged/loose "shreds" and morsels, frozen-to-fresh patties with mixers, and treats.
Freshpet Select (and Vital Freshpet Select). The foundational mainstream line and the entry point for most new households. Rolls and bags across chicken, beef, turkey and mixed-protein recipes; grain-inclusive and grain-free options; dog and cat. Target customer: the mass and grocery shopper trading up from premium kibble without a step-change in daily cost. Freshpet cites a daily cost as low as roughly $1.50 for a 30-pound dog on refrigerated rolls — the lowest daily cost in the fresh category and the core of the "accessible fresh" positioning. Pricing model: conventional wholesale-to-retail, no subscription.
Vital. The premium, higher-animal-protein tier positioned around ancestral-diet nutrition. 100% non-GMO, no preservatives, complete and balanced for all life stages; available as rolls, bags and shreds for both dogs and cats; includes grain-free and chicken-free recipes for dietary sensitivity. Flagship SKUs include the grain-free wild Alaskan pollock and salmon recipe with spinach, cranberries, blueberries and sweet potato. Target customer: pet-specialty and premium grocery shopper. Trademark "Vital" is registered to the company.
Vital Balanced Nutrition. A line extension of Vital adding fibre-rich whole grains for digestive health; two roll SKUs and one bagged recipe. Positioned for dogs where grain-free is not desired.
Nature's Fresh. The ethical-sourcing and sustainability tier. Chicken complies with Global Animal Partnership (GAP) humane standards; vegetables and grains sourced from regenerative farms; antibiotic-free and vegetarian-fed protein. Available in rolls and bags, grain and grain-free, for dogs and cats. Formulas are cited at roughly 85% animal protein with brown rice, eggs and carrots. Target customer: the values-driven natural-channel shopper. Registered trademark.
Homestyle Creations. A two-part system pairing gently cooked chicken or beef patties with fresh fruit or vegetable mixers, assembled by the pet parent into a complete balanced meal — the closest analogue to home cooking sold at retail. 100% natural, no preservatives, US-sourced meats, complete and balanced for adult dogs, sold in 1 lb formats at Walmart, PetSmart and elsewhere. Target customer: the shopper who would otherwise home-cook. Registered trademark.
Deli Fresh. A club-channel line using antibiotic-free chicken and non-GMO ingredients, grain-free, sold exclusively through Costco. Strategically important because Costco alone represents 10% of FY2025 net sales; the exclusive line is the mechanism by which club economics are managed without cannibalising grocery pricing. Trademark "DeliFresh" is registered.
Roasted Meals / Freshly Roasted Meals. A bagged, roasted-format range of three recipes, one grain-free, with chicken and chicken liver leading the ingredient deck on the chicken variants and pea protein/pea fibre as the grain alternative in the grain-free SKU. This platform is the principal beneficiary of the new bag-manufacturing technology commissioned in 2025–2026. Trademark "Roasted Meals" is registered.
Spring & Sprout. Launched September 2021 as the first fresh, refrigerated 100% vegetarian dog food available at retail. Developed by Freshpet's in-house veterinary nutritionist; combines plant proteins with cage-free eggs, carrots and cranberries. Initial distribution 900+ Petco stores, with broader rollout from 2022. Target customer: the plant-forward household; also a sustainability proof point.
Dog Joy (Freshpet Dog Joy) and Dognation — fresh treats. Refrigerated treats across all classes of retail, real meat as first ingredient, no by-products or artificial flavours. Flagship SKU: Dog Joy turkey bacon treats. Treats are strategically a trial-generating and basket-building device rather than a margin engine. Both are registered trademarks.
Cat food. Vital and Nature's Fresh both extend to cats in rolls and shreds. Cat remains materially smaller than dog and is not separately quantified. The company competes primarily in the US dog and cat food market, but its stated market-share metric (4.2%) is against dog food and treats only.
Direct-to-consumer meal plans. The company website offers customised meal plans delivered fresh to the door. This is the only recurring-revenue-shaped offering in the portfolio; economics, subscriber counts and revenue contribution are not publicly disclosed. Management identified e-commerce (~14% of FY2025 sales) and DTC expansion as a 2026 growth priority.
The Freshpet Fridge — the platform product. Not sold, but the most important physical product in the portfolio. Specifications: typically 4 ft wide × 7 ft high; edge-lit LED headers; LED interior lighting; black interiors; frameless glass swing doors; eco-friendly refrigerants (over 90.9% of the active fleet uses refrigerants such as R-290); latest units from True Manufacturing and Minus 40 consume up to 91% less electricity than older models. Designed in-house in collaboration with global commercial refrigeration manufacturers; installed and maintained by third-party service providers; audited photographically by brokerage partners. In 2025 the company began testing island fridges, described by the CEO as the most significant step-change in retail visibility and availability the company has attempted.
Product Portfolio
| Product line | Primary format | Species | Channel emphasis | Launch / status |
|---|---|---|---|---|
Freshpet Select | Rolls, bags | Dog, cat | Grocery, mass | Core legacy line |
Vital | Rolls, bags, shreds | Dog, cat | Pet specialty, premium grocery | Core premium line |
Vital Balanced Nutrition | Rolls, bag | Dog | Pet specialty | Line extension |
Nature's Fresh | Rolls, bags | Dog, cat | Natural, grocery | Core ethical-sourcing line |
Homestyle Creations | Patties plus mixers | Dog | Mass, pet specialty | Growth line |
Deli Fresh | Rolls | Dog | Club (Costco exclusive) | Channel-exclusive |
Roasted Meals | Bags | Dog | Grocery, mass | Beneficiary of new bag technology |
Spring & Sprout | Rolls | Dog | Pet specialty | Launched Sept 2021 |
Dog Joy / Dognation | Treats | Dog | All classes | Core treats |
DTC meal plans | Direct shipment | Dog, cat | Digital | Expanding, undisclosed scale |
Financial Narrative
6.1 Income statement
6.2 Margins
6.3 Balance sheet
Freshpet carries no goodwill and no separately material intangible asset balance — a direct consequence of an entirely organic history with no acquisitions.
6.4 Cash flow
6.5 Ratios
Calculated on ending balance-sheet values for comparability; FY2021–FY2023 balance-sheet inputs were not verified from primary sources and are therefore omitted.
6.6 Commentary on trends, inflections and drivers
Revenue. The five-year record is one of exceptional compounding followed by a sharp deceleration. Net sales grew at a 26.9% CAGR from FY2021 to FY2025, but the annual sequence — 33.5%, 39.9%, 28.8%, 27.2%, 13.0% — makes plain that FY2025 was a break, not a taper. Management attributes it to a meaningful shift in consumer sentiment in 2025 that slowed the entire fresh category; the CEO's letter to stockholders concedes the shift "prompted a comprehensive reassessment of our strategy." Critically, growth in FY2025 remained ahead of the dog food category, so the deceleration is a category event, not a share event. The 2026 reacceleration (14.3% in H1, 15.5% in Q2) is materially volume-driven, with price/mix negative — the company is buying volume with value engineering at entry price points rather than harvesting price.
Gross margin. The most impressive line in the five years. Gross margin collapsed from 38.1% in FY2021 to 31.2% in FY2022 under plant start-up costs ($26.1m of start-up expense in adjusted gross profit that year), ingredient and labour inflation, and quality problems — the nadir was Q4 2022 at 27.6%. It then recovered to 32.7%, 40.6% and 40.8%, with adjusted gross margin reaching 46.7% in FY2025 and 48.6% in Q2 2026. Three drivers explain the recovery: fixed-cost leverage as Ennis lines ramped, the near-elimination of quality costs, and disciplined input sourcing. The Q2 2026 print is the cleanest evidence yet that the manufacturing platform is structurally, not cyclically, more profitable — management raised the FY2027 adjusted gross margin floor from 48% to at least 49% explicitly on the basis of operating gains achieved before the new technology contributes.
SG&A. SG&A as a percentage of sales has fallen every year, from 43.9% to 33.9%, and adjusted SG&A from 29.9% to 29.0%. But the composition matters. FY2025 SG&A absorbed $29.2m of incremental media spend and $17.7m of non-recurring charges (a $10.7m distributor receivable write-off, $5.7m of Phillips litigation settlement charges, and $1.3m of international restructuring), while benefiting from a $37.9m swing down in share-based compensation as performance conditions were reassessed. In H1 2026 the direction reversed: SG&A rose to 37.0% of sales on higher logistics costs (6.9% of net sales in Q2 2026 versus 5.7% a year earlier, with a further ~$8m of cost expected for the year) and variable compensation accruals. Logistics is now the principal margin headwind.
Net income and the tax inflection. FY2025 net income of $139.1m is not an operating result. It is $70.8m of pre-tax income plus a $68.4m income tax benefit driven overwhelmingly by the release of the deferred tax valuation allowance following sustained and expected profitability. The economically comparable figure is pre-tax income of $70.8m against $47.5m in FY2024 — a 49% increase, still strong, but a fraction of the headline. From FY2026 the company is a cash-and-book taxpayer at a normalised rate (Q2 2026 tax expense $6.1m on $25.6m pre-tax, ~24%), and prior-period EPS comparisons are therefore structurally misleading. Federal NOL carryforwards stood at approximately $391.1m and state NOLs at approximately $275.4m as of 31 December 2025, subject to Section 382 limitations the company has already quantified and incorporated.
Cash flow — the single most important inflection. Free cash flow ran at negative $163.2m in FY2023, negative $32.8m in FY2024, and turned positive at $12.4m in FY2025 — a year earlier than the company's own goal — and $27.4m in H1 2026. The swing is driven far more by capital discipline than by operating cash flow: operating cash flow rose only from $154.3m to $160.6m between FY2024 and FY2025, while capex fell from $187.1m to $148.2m, having peaked at $239.1m in FY2023. Management progressively cut the FY2025 capex plan from ~$225m to ~$175m to ~$140m across the year. FY2026 guidance holds capex at ~$150m. This is the pivot from "growth at any capital cost" to "growth within cash generation," and it is what enabled the buyback.
Balance sheet and capital structure. Freshpet carried no debt at all through FY2022. In March 2023 it issued convertible senior notes for $393.5m of net proceeds and simultaneously purchased $66.2m of capped call options to mitigate dilution — an implied face amount of approximately $402.5m given the $397.3m carrying value net of $5.2m unamortised issuance costs at 31 December 2025. The specific coupon and maturity were not re-verified from a primary source in this review and are therefore not stated; FY2025 interest expense of $14.1m implies an all-in cost of roughly 3.5% including issuance cost amortisation. Net debt to adjusted EBITDA is a comfortable 0.76x at FY2025 and 0.37x on H1 2026 annualised figures. The diluted share count jumped from 50.3m to 56.0m in FY2025 because profitability triggered if-converted treatment of the notes — a mechanical 11% dilution to diluted EPS that recurs going forward.
Working capital. The cash conversion cycle improved from 51.8 days to 40.4 days in FY2025, driven by an 8-day reduction in days inventory outstanding and a 4.5-day reduction in days sales outstanding. Some of the DSO improvement is artefactual — the $12.1m provision for loss on accounts receivable in FY2025 relates to the distributor liquidation, not to collection improvement. Inventories rebuilt in H1 2026 ($86.7m from $76.8m) ahead of new line ramp-ups.
Financial Detail
Segment Revenue
| Segment | Contents | FY2023 net sales (USD M) | FY2024 net sales (USD M) | FY2025 net sales (USD M) | FY2025 % of total |
|---|---|---|---|---|---|
Single reportable segment (fresh dog food, cat food, dog treats) | Entire business | 766.9 | 975.2 | 1102.0 | 100 |
Segment Revenue
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Segment (consolidated) net sales (USD M) | 766.9 | 975.2 | 1102.0 |
YoY growth (%) | 28.8 | 27.2 | 13.0 |
Segment (consolidated) income from operations (USD M) | -30.4 | 38.0 | 75.7 |
Operating margin (%) | -4.0 | 3.9 | 6.9 |
Income before income taxes (USD M) | nd | 47.5 | 70.8 |
Segment Revenue
| Class of trade | Description | Revenue disclosed |
|---|---|---|
Grocery | Supermarket chains; the original and largest fridge base | No |
Mass | Mass merchandisers; Walmart is the single largest customer at 25% of FY2025 net sales | No |
Club | Warehouse clubs; Costco at 10% of FY2025 net sales; Deli Fresh is a Costco-exclusive line | No |
Pet specialty | Petco, PetSmart and independents, largely served via distributors | No |
Digital | E-commerce and retail media; e-commerce cited at ~14% of FY2025 total sales | Partially |
International | Canada and Europe, including four UK retailers across ~637 stores | No |
Segment Revenue
| Metric | FY2024 | FY2025 | H1 2026 | Q2 2026 |
|---|---|---|---|---|
Net sales growth (%) | 27.2 | 13.0 | 14.3 | 15.5 |
Volume contribution (pts) | nd | 12.0 | 15.1 | 15.7 |
Price/mix contribution (pts) | nd | 1.0 | -0.8 | -0.2 |
Financial Analysis
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Net sales (USD M) | 425.5 | 595.3 | 766.9 | 975.2 | 1102.0 |
Net sales growth (%) | 33.5 | 39.9 | 28.8 | 27.2 | 13.0 |
Cost of goods sold (USD M) | 263.3 | 409.3 | 516.0 | 579.2 | 652.4 |
Gross profit (USD M) | 162.1 | 186.0 | 250.9 | 396.0 | 449.6 |
SG&A (USD M) | 186.8 | 238.0 | 281.3 | 358.0 | 374.0 |
Income (loss) from operations (USD M) | -24.7 | -52.0 | -30.4 | 38.0 | 75.7 |
Interest and other income, net (USD M) | nd | nd | nd | 11.9 | 9.2 |
Interest expense (USD M) | nd | nd | nd | 12.3 | 14.1 |
Gain on equity investment (USD M) | 0.0 | 0.0 | 0.0 | 9.9 | 0.0 |
Income (loss) before income taxes (USD M) | nd | nd | nd | 47.5 | 70.8 |
Income tax expense (benefit) (USD M) | nd | nd | nd | 0.6 | -68.4 |
Net income (loss) (USD M) | -29.7 | -59.5 | -33.6 | 46.9 | 139.1 |
EBITDA, GAAP reconciliation basis (USD M) | nd | nd | nd | 118.7 | 162.5 |
Adjusted EBITDA (USD M) | 43.0 | 20.1 | nd | 161.8 | 195.7 |
Adjusted gross profit (USD M) | nd | nd | nd | 453.5 | 515.2 |
Adjusted SG&A (USD M) | nd | nd | nd | 291.6 | 319.4 |
EPS basic (USD) | -0.69 | -1.29 | -0.70 | 0.97 | 2.85 |
EPS diluted (USD) | -0.69 | -1.29 | -0.70 | 0.93 | 2.64 |
Weighted average diluted shares (M) | nd | nd | nd | 50.3 | 56.0 |
Dividends per share (USD) | 0 | 0 | 0 | 0 | 0 |
Financial Analysis
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 38.1 | 31.2 | 32.7 | 40.6 | 40.8 |
Adjusted gross margin (%) | nd | nd | nd | 46.5 | 46.7 |
SG&A as % of net sales (%) | 43.9 | 40.0 | 36.7 | 36.7 | 33.9 |
Adjusted SG&A as % of net sales (%) | nd | nd | nd | 29.9 | 29.0 |
Operating margin (%) | -5.8 | -8.7 | -4.0 | 3.9 | 6.9 |
Adjusted EBITDA margin (%) | 10.1 | 3.4 | nd | 16.6 | 17.8 |
Net margin (%) | -7.0 | -10.0 | -4.4 | 4.8 | 12.6 |
Revenue CAGR FY2021–FY2025 (%) | 26.9 | 26.9 | 26.9 | 26.9 | 26.9 |
Financial Analysis
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | H1 2026 |
|---|---|---|---|---|---|---|
Cash and cash equivalents (USD M) | 72.8 | 132.7 | 296.9 | 268.6 | 278.0 | 350.8 |
Accounts receivable, net (USD M) | nd | nd | nd | 68.4 | 63.8 | 65.4 |
Inventories, net (USD M) | nd | nd | nd | 80.8 | 76.8 | 86.7 |
Total current assets (USD M) | nd | nd | nd | 437.0 | 435.7 | 517.1 |
Property, plant and equipment, net (USD M) | nd | nd | nd | 1065.9 | 1138.7 | 1146.3 |
Deferred tax assets, net (USD M) | 0.0 | 0.0 | 0.0 | 0.0 | 68.9 | 47.4 |
Long-term equity investment (USD M) | nd | nd | nd | 33.4 | 33.4 | 0.0 |
Total assets (USD M) | nd | nd | nd | 1574.9 | 1777.8 | 1812.4 |
Total current liabilities (USD M) | nd | nd | nd | 98.9 | 78.6 | 85.5 |
Convertible senior notes, net (USD M) | 0.0 | 0.0 | 393.5 | 395.2 | 397.3 | 398.4 |
Finance lease liabilities, total (USD M) | nd | nd | nd | 25.4 | 30.4 | 29.0 |
Operating lease liabilities, total (USD M) | nd | nd | nd | 3.5 | 67.3 | 66.2 |
Total liabilities (USD M) | nd | nd | nd | 519.5 | 569.1 | 574.7 |
Total stockholders' equity (USD M) | nd | nd | nd | 1055.4 | 1208.7 | 1237.7 |
Net debt, incl. finance leases (USD M) | -72.8 | -132.7 | 96.6 | 152.0 | 149.7 | 76.6 |
Working capital (USD M) | nd | nd | nd | 338.1 | 357.1 | 431.5 |
Goodwill (USD M) | 0 | 0 | 0 | 0 | 0 | 0 |
Financial Analysis
| Metric | FY2023 | FY2024 | FY2025 | H1 2026 |
|---|---|---|---|---|
Net cash provided by operating activities (USD M) | 75.9 | 154.3 | 160.6 | 84.8 |
Capital expenditures (USD M) | 239.1 | 187.1 | 148.2 | 57.3 |
Free cash flow (USD M) | -163.2 | -32.8 | 12.4 | 27.4 |
Depreciation and amortisation, cash flow basis (USD M) | 58.5 | 73.6 | 89.7 | 50.0 |
Share-based compensation (USD M) | 24.9 | 51.8 | 13.9 | 15.5 |
Proceeds from sale of equity investment (USD M) | 0.0 | 0.0 | 0.0 | 100.0 |
Dividends paid (USD M) | 0.0 | 0.0 | 0.0 | 0.0 |
Share repurchases (USD M) | 0.0 | 0.0 | 0.0 | 54.4 |
Net cash from financing activities (USD M) | 327.3 | 4.6 | -3.0 | -54.6 |
Financial Analysis
| Metric | FY2024 | FY2025 |
|---|---|---|
Return on equity (%) | 4.4 | 11.5 |
Return on assets (%) | 3.0 | 7.8 |
Return on invested capital, NOPAT at 21% (%) | 2.5 | 4.4 |
Current ratio (x) | 4.42 | 5.54 |
Debt to equity, incl. finance leases (x) | 0.40 | 0.35 |
Net debt to adjusted EBITDA (x) | 0.94 | 0.76 |
Interest coverage, EBIT/interest expense (x) | 3.1 | 5.4 |
Asset turnover (x) | 0.62 | 0.62 |
Days inventory outstanding (days) | 50.9 | 43.0 |
Days sales outstanding (days) | 25.6 | 21.1 |
Days payables outstanding (days) | 24.7 | 23.7 |
Cash conversion cycle (days) | 51.8 | 40.4 |
Geographic Revenue
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
United States net sales (USD M) | nd | nd | nd |
Canada net sales (USD M) | nd | nd | nd |
Europe net sales (USD M) | nd | nd | nd |
Total net sales (USD M) | 766.9 | 975.2 | 1102.0 |
Geographic Revenue
| Metric | FY2024 | FY2025 | H1 2026 |
|---|---|---|---|
Retail stores with Freshpet Fridges (units) | nd | 30235 | 30721 |
Stores with multiple fridges (%) | nd | 24 | 25 |
US household penetration (millions of households) | nd | 15.2 | nd |
UK stores carrying Freshpet (units) | nd | 637 | nd |
UK retail customers (count) | nd | 4 | nd |
E-commerce share of net sales (%) | nd | 14 | nd |
Total chiller fleet capacity (million cubic feet) | nd | 2.1 | nd |
Capital Markets
| Index | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
Freshpet, Inc. (USD) | 100.00 | 67.10 | 37.16 | 61.10 | 104.31 | 42.91 |
NASDAQ Composite (USD) | 100.00 | 121.39 | 81.21 | 116.47 | 149.83 | 180.33 |
Russell 3000 (USD) | 100.00 | 124.00 | 98.61 | 122.23 | 150.18 | 172.69 |
Capital Markets
| Metric | Value | As of |
|---|---|---|
Share price (USD) | 72.31 | 12 Aug 2026 |
Share price (USD) | 72.76 | 14 Aug 2026 |
Market capitalisation (USD bn) | ~3.5 | 14 Aug 2026 |
Shares outstanding (M) | 48.6 | 30 Jun 2026 |
Float (M) | 47.2 | Aug 2026 |
1-year return | Approximately +32% from ~$55 in early September 2025 to ~$72.76 | Aug 2026 |
3-year and 5-year returns | Negative; see the index table above | 31 Dec 2025 |
52-week range (USD) | Sources conflict: 46.76 to 164.07 is reported by one vendor, but the $164.07 high dates from the late-2024 peak and appears stale for an August 2026 trailing window. The verified trough in the period was approximately $52.27 (September 2025) | Aug 2026 |
Aggregate market value held by non-affiliates (USD bn) | 3.3 | 30 Jun 2025 |
Short interest as % of shares outstanding | ~12.8 | Recent third-party compilation |
Beta | 1.72 | Third-party compilation |
Capital Markets
| Metric | Value | Basis |
|---|---|---|
Market capitalisation (USD bn) | 3.52 | 48.6m shares at $72.31 |
Net debt (USD M) | 76.6 | Convertible notes $398.4m plus finance leases $29.0m less cash $350.8m, at 30 Jun 2026 |
Enterprise value (USD bn) | ~3.60 | Derived |
EV / FY2026E net sales (x) | ~2.9 | Against guidance-implied revenue of approximately $1,212–1,234m |
EV / FY2026E adjusted EBITDA (x) | ~16.7 | Against $215m guidance midpoint |
EV / TTM adjusted EBITDA (x) | ~17.5 | TTM adjusted EBITDA of approximately $205.9m (FY2025 $195.7m less H1 2025 $79.9m plus H1 2026 $90.1m) |
Price / book (x) | ~2.8 | Equity of $1,237.7m at 30 Jun 2026 |
P/E, TTM reported (x) | ~20 | Heavily distorted by the FY2025 valuation-allowance release and the H1 2026 Ollie gain; not a meaningful comparison |
Dividend yield (%) | 0 | No dividend |
Capital Markets
| Source | Coverage count | Consensus rating | Mean / median price target (USD) | Range (USD) |
|---|---|---|---|---|
Investing.com | 16 | Buy (11 buy, 8 hold, 0 sell — as reported) | 71.13 mean | 50 to 101 |
TickerNerd compilation | 25 | Strong Buy (14 buy, 4 hold, 1 sell) | 97.00 median; 110.00 mean | 65 to 158 |
StockAnalysis | nd | Buy | 77.00 | nd |
Simply Wall St | 36 covering, 18 contributing estimates | Mixed | Consensus target revised down from 94.18 to 88.69 in late August, citing decelerating growth and competition from Chewy fresh | nd |
Capital Markets
| Item | Detail |
|---|---|
Dividend history | No cash dividend declared or paid since the February 2014 IPO |
Dividend policy | No dividend anticipated in the foreseeable future; any future determination at Board discretion subject to financial condition, cash requirements and contractual restrictions |
Buyback authorisation | Up to $150m authorised 21 May 2026; effective immediately; no fixed expiration; executable via open market, negotiated transactions or a 10b5-1 plan; may be suspended or discontinued at any time |
Buyback execution | $54.4m executed in H1 2026 (including broker fees and excise tax); 1,046,000 treasury shares held at 30 Jun 2026 versus 14,000 at 31 Dec 2025 |
Prior repurchases | None — the FY2025 10-K Item 5 reports no issuer purchases of equity securities |
Credit ratings — Moody's | Not publicly disclosed; the company does not appear to carry a public corporate rating |
Credit ratings — S&P Global | Not publicly disclosed |
Credit ratings — Fitch | Not publicly disclosed |
Capital Markets
| Instrument | Carrying value at 30 Jun 2026 (USD M) | Maturity | Notes |
|---|---|---|---|
Convertible senior notes, net of unamortised issuance costs | 398.4 | Coupon and maturity date not verified from a primary source in this review; issued March 2023 with $393.5m net proceeds and an implied face amount of approximately $402.5m | Hedged by $66.2m of capped call options purchased at issuance; if-converted treatment now applies to diluted EPS, adding roughly 6.6m shares |
Finance lease liabilities — current | 2.4 | Within 12 months | — |
Finance lease liabilities — long term | 26.6 | Beyond 12 months | — |
Operating lease liabilities — current | 2.2 | Within 12 months | — |
Operating lease liabilities — long term | 64.0 | Beyond 12 months | Increased sharply in 2025 with the new warehouse lease and headquarters arrangements |
Revolving credit facility | None disclosed as drawn | — | — |
Analyst Conclusions
22.1 Management guidance
Guidance-implied FY2026 net sales are approximately $1,212m to $1,234m. Management explicitly flagged a Q3 2026 comparison headwind exceeding two percentage points arising from a large club customer's 2025 shipment timing and a July 4 ordering shift, which implies a meaningfully stronger Q4 to reach the guided range.
22.2 Consensus expectations
Consensus is unusually dispersed. Price targets span $50 to $158 across the full coverage universe of 25 to 36 analysts, with median estimates clustered between $71 and $97 depending on the compilation. Adjusted EBITDA guidance of $215m at the midpoint sits above the pre-release consensus of $211.1m. One third-party narrative model projects $1.5bn of revenue and $126.8m of earnings by 2029, implying 8.9% annual revenue growth — materially below management's near-term guidance and below the current 15% volume growth rate, which quantifies how much of the bear case rests on assumed deceleration rather than on current trading.
22.3 Bull case
One — the margin bridge is real and is running ahead of schedule. Adjusted gross margin reached 48.6% in Q2 2026, already above the original 48% FY2027 target, and management raised the FY2027 floor to at least 49% while explicitly attributing the raise to operating gains achieved independently of new technology benefits. If the bag-technology lines deliver anything at all, the 49% floor is conservative. At 49% adjusted gross margin and 29% adjusted SG&A — already achieved in FY2025 — the 20–22% adjusted EBITDA margin target is arithmetic, not aspiration. On $1.4bn of FY2028 revenue that is $280m–$308m of adjusted EBITDA against $195.7m in FY2025.
Two — the capital cycle has turned and the cash is now free. Capex fell from $239.1m (FY2023) to $148.2m (FY2025) and is guided flat at ~$150m for FY2026, while operating cash flow rose to $160.6m and H1 2026 alone generated $84.8m. Free cash flow inflected a full year ahead of the company's own goal. The $100m Ollie proceeds and the $150m buyback authorisation demonstrate that the board now treats the balance sheet as a return vehicle rather than a construction budget. Every incremental dollar of revenue from here carries dramatically better incremental returns than the FY2021–FY2023 cohort.
Three — the distribution runway is quantified and unexhausted. 30,721 stores against roughly 46,000 US supermarkets excluding pet specialty; only 25% of stores carry multiple fridges; 15.2m households penetrated against a stated 36m household TAM; e-commerce at only 14% of sales with DTC and 700 rural lifestyle stores in rollout; and island fridges in test as a step-change in visibility. Freshpet grew volume 15.7% in Q2 2026 against a decelerating category — this is a share-gain story with several independent expansion vectors still unspent.
22.4 Bear case
One — reported earnings quality is far weaker than headline figures suggest. FY2025 net income of $139.1m contains a $68.4m tax benefit that will never recur; H1 2026 net income of $68.0m contains a $66.6m gain on the Ollie sale that will never recur. Strip both out and FY2025 pre-tax income was $70.8m on $1,102.0m of revenue — a 6.4% pre-tax margin — while H1 2026 income from operations was $26.0m on $603.2m, a 4.3% operating margin. The company is now a full cash taxpayer. ROIC on a 21% notional rate was approximately 4.4% in FY2025, below any credible cost of capital, and the diluted share count has permanently risen 11% to 56.0m through if-converted treatment of the notes. Investors paying 17.5x TTM EV/adjusted EBITDA are paying for a margin structure that does not yet exist.
Two — the competitive set has materially changed and the moat is not legal. General Mills now lists fresh foods among its North America Pet categories; Mars owns NomNomNow; Hill's bought Prime100; Costco — a 10% customer — and Chewy have both been cited by analysts as fresh entrants, with a consensus target cut explicitly attributed to Chewy fresh. Freshpet holds no disclosed patents. Its protections are sunk capital, trade secrets and employment agreements. Meanwhile the customer base is dangerously concentrated: ten customers at 68% of sales with no contractual purchase obligation, and the two largest at 35% combined. A single planogram decision at Walmart is a material adverse event, and the Q1 2025 distributor liquidation proved that channel failures arrive without warning and cost real money.
Three — the growth rate is category-dependent and the category has already proved fragile. In FY2025 net sales growth collapsed from 27.2% to 13.0% on a consumer sentiment shift, forcing three consecutive guidance cuts, the withdrawal of the 2027 $1.8bn revenue target, a 58.9% single-year decline in shareholder value, and a CFO departure. Management has already noted in mid-2026 that household penetration growth is slowing again on inflationary pressure. Price/mix is now negative — the company is buying volume, not earning it. Logistics costs rose from 5.7% to 6.9% of sales with a further $8m expected. And the 2027 revenue anchor has not been reinstated; management now commits only to growing "well in excess of the category," which is a relative promise that can be honoured at 6% growth in a 2% category. Five-year shareholder returns are negative 57% while the Nasdaq is up 80%; approximately 12.8% of the float is sold short.
22.5 Catalysts and monitorables — next twelve months
22.6 Analyst verdict (≈300 words)
Freshpet in August 2026 is a fundamentally different proposition from Freshpet in August 2025, and the market has only partly repriced it. Twelve months ago the company was cutting guidance for the third consecutive quarter, abandoning its 2027 revenue target, and losing its CFO. Today it is growing volume at 15.7%, has raised guidance twice, has lifted its 2027 gross margin floor, is generating free cash flow, and is buying back stock. That is about as clean a turn as a consumer company can execute in four quarters.
The bull and bear cases are not in dispute about the facts; they disagree about a single variable — terminal category share. If fresh refrigerated pet food is a format that reaches 10–15% of the $38bn dog food category, Freshpet's owned manufacturing and its 30,700-fridge fleet make it the near-certain principal beneficiary, and today's ~17x EV/EBITDA on a business heading to 20–22% margins is inexpensive. If fresh plateaus nearer today's ~4% share as a niche premium format, Freshpet is a mid-single-digit grower with a 4% ROIC, a concentrated customer base, no patent protection, and four multinationals plus two retail giants circling the same shelf.
The evidence tilts constructive but does not settle it. The margin bridge is verifiable and running ahead of schedule; the capital cycle has genuinely turned; the distribution runway is quantified and unexhausted. Against that, reported profits are inflated by a tax release and an asset sale that will not repeat, price/mix has gone negative, logistics costs are climbing, and the company itself declined to restate an absolute long-term revenue target — the most telling single signal in the entire disclosure record.
Verdict: constructive with a clear tripwire. The 2027 margin targets are credible and largely already earned. The revenue anchor is not. Position size to the margin story; monitor the volume story quarterly; and treat any renewed household-penetration deceleration, or a Walmart or Costco assortment change, as thesis-breaking rather than thesis-testing.
APPENDIX A: DATA GAPS AND DISCLOSURE LIMITATIONS
The following items requested in the specification could not be sourced from public disclosure and are recorded as not publicly disclosed rather than estimated:
- Geographic revenue split (US / Canada / Europe) for any year, and all country-level revenue.
- Revenue by class of trade (grocery, mass, club, pet specialty, digital, international).
- Segment operating income and segment margins — the company reports a single segment.
- Research and development expense, in absolute terms or as a percentage of revenue, for any of the five years.
- Patent portfolio size and recent patent grants.
- Direct-to-consumer subscriber count, revenue and unit economics.
- Credit ratings from Moody's, S&P Global or Fitch — the company does not appear to carry a public corporate rating.
- Published MSCI, Sustainalytics or CDP ESG ratings.
- Formal absolute or intensity-based greenhouse gas reduction targets — under evaluation but not adopted.
- Executive officer ages and educational backgrounds for all named executives other than the CEO.
- FY2023 and FY2024 employee headcounts (disclosed in prior filings but not verified from a primary source in this review).
- FY2023 adjusted EBITDA; FY2021 and FY2022 operating cash flow, capital expenditure and full balance sheets (disclosed in prior filings but not verified in this review).
- FY2025 named executive officer compensation and FY2024 CEO compensation (disclosed in the respective proxies but not verified in this review).
- The convertible senior notes' stated coupon and maturity date (a face amount of approximately $402.5m is implied by the carrying value and unamortised issuance costs).
- The precise physical location of "Freshpet Kitchens South" as distinct from the Bethlehem, Pennsylvania estate itemised in Item 2 of the FY2025 Form 10-K.
- Revenue figures for Nestlé Purina PetCare, Mars Petcare, J.M. Smucker's pet segment and Post Holdings' pet food platform, and for all private fresh competitors.
APPENDIX B: NOTED SOURCE CONFLICTS
- US dog food market size. The company cites approximately $38bn for dog food and treats (NIQ omnichannel, 52 weeks ended 28 March 2026); Euromonitor, as cited by Morningstar in August 2026, sizes the US dog food market at approximately $42bn. The gap reflects differing category definitions (inclusion of treats, channel coverage) and panel methodology.
- Vanguard ownership. Aggregator data from January 2026 shows The Vanguard Group at approximately 10.56% (5.15m shares); the Schedule 13G filed 29 April 2026 by Vanguard Capital Management reports 5.23% (2,565,954 shares). The divergence is explained by Vanguard's completed internal realignment into Vanguard Capital Management and Vanguard Portfolio Management in early January 2026. Primary filings should be preferred.
- Wasatch ownership. Aggregator data from January 2026 shows 7.74% (3.78m shares); the Schedule 13G/A filed 15 July 2026 reports 5.7% (2,819,293 shares) — a genuine position reduction, not a methodology artefact.
- Analyst consensus. Investing.com reports 16 analysts with a mean target of $71.13; a separate compilation reports 25 analysts with a median of $97.00 and a mean of $110.00; StockAnalysis reports $77.00; Simply Wall St reports a consensus revised down to $88.69. Coverage universes and vintages differ.
- 52-week trading range. One vendor reports $46.76 to $164.07; the $164.07 high dates from the late-2024 peak and appears stale for an August 2026 trailing twelve-month window. A verified trough near $52.27 was observed in September 2025.
- Institutional ownership percentage. Aggregators report headline institutional ownership above 100% of shares outstanding (113.78% and 127.22% in two compilations), reflecting double-counting of shares out on loan; these figures should not be read as literal ownership.
- Employee count. The FY2025 Form 10-K states 1,288 employees at 31 December 2025; the 24 June 2026 press release cites "about 1,300 employees worldwide." One third-party encyclopaedia entry lists 591 employees, which is stale and contradicted by primary filings.
- FY2025 net sales rounding. Reported as $1,102.0m in the release and $1,102,015 thousand in the audited statements; the FY2024 comparative is $975.2m / $975,177 thousand.
Executive Leadership
| Name | Title | Appointed | Prior roles | Education | Age |
|---|---|---|---|---|---|
William B. ("Billy") Cyr | Chief Executive Officer and Director | September 2016 | President & CEO, Sunny Delight Beverages Co. (2004–2016); 19 years at Procter & Gamble, latterly VP & GM North American Juice and Global Nutritional Beverages | A.B., Princeton University | 63 |
Scott Morris | President and Co-Founder | President since March 2016; co-founder 2006 | COO Freshpet Jul 2015–Aug 2024; CMO Jan 2014–Jul 2015; SVP Sales & Marketing 2010–2013; VP Marketing, The Meow Mix Company 2002–2006; Ralston Purina 1990–2002, latterly Pet Food Group Director | nd | nd |
Nicola ("Nicki") Baty | Chief Operating Officer; becomes President & COO October 2026 | Joined 2024 as COO | nd | nd | nd |
John O'Connor | Chief Financial Officer | Effective 9 February 2026 | nd | nd | nd |
Thembeka ("Thembi") Machaba | Chief Human Resources Officer; becomes CHRO & Chief Administrative Officer October 2026 | CHRO; SVP HR previously | nd | nd | nd |
Ivan Garcia | SVP, Finance | Interim CFO 17 Oct 2025 – Feb 2026; VP Finance from July 2023 | Finance roles at Freshpet since before the February 2014 IPO | nd | nd |
Ana Lopez | SVP, Supply Chain | Effective 2 February 2026 | nd | nd | nd |
Rachel Perkins-Ulsh | VP, Investor Relations & Corporate Communications | nd | nd | nd | nd |
| Date | Change | Context |
|---|---|---|
Aug 2024 | Scott Morris relinquishes COO role | Nicki Baty recruited as COO; Morris retains President title |
7 Oct 2025 | Todd Cunfer departs as CFO; Ivan Garcia named Interim CFO effective 17 Oct 2025 | External search launched with a leading executive search firm; shares fell 6.4% on the day |
4 Feb 2026 | John O'Connor named CFO effective 9 Feb 2026; Ana Lopez named SVP Supply Chain effective 2 Feb 2026; Garcia to SVP Finance | FY2025 guidance simultaneously reaffirmed |
9 Feb 2026 | Inducement grant to O'Connor of 7,500 RSUs vesting 33.3%/33.3%/33.4% over three years | Granted outside the 2024 Equity Incentive Plan under Nasdaq Rule 5635(c)(4) |
24 Jun 2026 | Scott Morris to move from operating duties to an 18-month advisory role effective 20 October 2026; Nicki Baty to become President & COO; Thembi Machaba promoted to CHRO & Chief Administrative Officer with expanded oversight of sustainability, community relations and administration | Aligned to the company's 20th anniversary; a genuine founder-succession event |
| Name | Age | Director since | Independent | Committees | Principal background | Other public boards |
|---|---|---|---|---|---|---|
Walter N. George III | 69 | Nov 2014 | Yes — Chair of the Board since 2023 | None | President, G3 Consulting; former President, American Italian Pasta Co.; senior operating roles at Hill's Pet Nutrition 1988–2001, latterly VP Supply Chain | None disclosed |
William B. Cyr | 63 | Sept 2016 | No (CEO) | None | See above | Vital Farms, Inc. (Nasdaq: VITL) since July 2025 |
Olu Beck | 59 | Oct 2019 | Yes | Operations & FSQA | Founder/CEO, The Beck Group NJ; former CEO of Wholesome Inc.; CFO of BEN'S ORIGINAL; senior roles at Mars Inc. and Johnson & Johnson | Saputo Inc. (TSX: SAP) |
David B. Biegger | 67 | May 2023 | Yes | Audit; Operations & FSQA (Chair) | Operating Partner, Shore Capital Partners; EVP & Chief Supply Chain Officer, Conagra Brands 2015–2021; Campbell Soup 2005–2015; P&G early career | None disclosed |
Daryl G. Brewster | 69 | Jan 2011 | Yes | Compensation & HCM (Chair) | CEO of CECP; founder/CEO Brookside Management; CEO Krispy Kreme 2006–2008; senior executive at Nabisco/Kraft 1996–2006 | None disclosed |
Jacki S. Kelley | 59 | Feb 2019 | Yes | Compensation & HCM | EVP, Chief Client Officer & Business Officer at Omnicom (post-IPG acquisition); CEO Americas at Dentsu 2020–2023; Bloomberg COO/Deputy COO | None disclosed |
Lauri Kien Kotcher | 65 | Apr 2024 | Yes | Nominating & Governance | CEO & Co-Founder, Different Day LLC; CEO of Quip NYC 2023–2025; CEO The Shade Store; CEO Hello Products; CMO Godiva; 15 years at McKinsey | None disclosed |
Timothy R. McLevish | 71 | Aug 2023 | Yes — Audit Committee Financial Expert | Audit | CFO at five public companies: Carrier, Walgreens Boots Alliance, Kraft Foods Group, Ingersoll-Rand, Mead | Revlon, Inc. since April 2023 |
Leta D. Priest | 66 | Sept 2018 | Yes | Nominating & Governance (Chair) | SVP & General Merchandising Manager, Fresh Food at Walmart 2009–2015; VP Corporate Brands North America at Safeway | None disclosed (private: Milo's Tea) |
Joseph E. Scalzo | 67 | Aug 2023 | Yes | Nominating & Governance | CEO, President & Director of The Simply Good Foods Company since Jan 2026; former CEO of Atkins Nutritionals and WhiteWave Foods; Dean Foods, Gillette, Coca-Cola, P&G | The Simply Good Foods Company (Nasdaq: SMPL) |
Craig D. Steeneck | 68 | Nov 2014 | Yes — Audit Committee Financial Expert | Audit (Chair); Operations & FSQA | EVP & CFO, Pinnacle Foods 2007–2019; CFO International Home Foods; CFO roles at Cendant Timeshare and Resorts Condominiums | Utz Brands, Inc. (NYSE: UTZ), Audit Chair |
David J. West | 63 | Jul 2023 | Yes | Compensation & HCM | Partner, Centerview Capital Consumer; CEO & President of Del Monte Foods 2011–2015 and of Big Heart Pet Brands; CEO & President of The Hershey Company 2007–2011 | Advantage Solutions Inc. (Nasdaq: ADV); The Simply Good Foods Company |
| Attribute | Detail |
|---|---|
Board size | 12 directors |
Independence | 11 of 12 independent; only the CEO is non-independent; all four committees composed entirely of independent directors |
Chair/CEO separation | Yes — independent non-executive Chair (Walter N. George III) |
Classification | Fully declassified as of the 2025 annual meeting; annual election of all directors |
Voting standard | Majority of votes cast in uncontested elections; plurality in contested; director resignation policy in force |
Poison pill | None |
Supermajority provisions | None |
Proxy access | Yes — up to 20 stockholders holding 3% for three years |
Special meetings | Stockholders may request the company call a special meeting |
Director tenure policy | Non-employee directors not renominated after age 75 |
Clawback | Compensation Recoupment Policy adopted October 2023, Dodd-Frank/Nasdaq compliant |
Conflict of interest policy | Adopted February 2024 in response to 2023 stockholder concerns |
Diversity | 4 of 12 directors diverse; 4 women and 1 African American among the 11 independent directors |
Board refreshment | Five new directors appointed since 2023 |
| Executive | Salary | Stock awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|
Scott Morris, President & COO | 550192 | 0 | 905205 | 13800 | 1469197 |
Todd Cunfer, CFO | 520192 | 749911 | 856275 | 13800 | 2140178 |
Thembeka Machaba, CHRO | 401346 | 0 | 781625 | 13800 | 1196771 |
Nicola Baty, COO | 266860 | 2310791 | 381568 | 550000 | 3509219 |
| Holder | Shares | % of class | Source and date |
|---|---|---|---|
BlackRock (funding entity) | 5620000 | 11.52 | Aggregator compilation, January 2026 |
The Vanguard Group (aggregate) | 5150000 | 10.56 | Aggregator compilation, January 2026 |
Vanguard Capital Management | 2565954 | 5.23 | Schedule 13G filed 29 April 2026 |
Wasatch Advisors LP | 2819293 | 5.70 | Schedule 13G/A filed 15 July 2026 |
Wasatch Advisors LP (earlier) | 3780000 | 7.74 | Aggregator compilation, January 2026 |
Point72 / Steven Cohen entities | 966750 | 1.75 | Third-party institutional data, July 2026 |
State Street Corporation | nd | nd | Not verified |
Other institutions (aggregate) | nd | nd | Aggregators report headline institutional ownership above 100% of shares outstanding, reflecting double-counting of lent and short-covered shares |
Competitive Landscape
| Competitor | Ownership | Relevant scale | Positioning versus Freshpet |
|---|---|---|---|
Nestlé Purina PetCare | Nestlé S.A. | Largest US pet food business; segment revenue not verified in this review | The dominant incumbent across dry, wet and treats; unmatched media weight, R&D and retail leverage. Freshpet's principal share donor |
Mars Petcare | Mars, Incorporated (private) | Global pet food leader; owns NomNomNow, acquired in the fresh consolidation wave | The other giant; already inside fresh via NomNomNow and vet-channel adjacencies |
Hill's Pet Nutrition | Colgate-Palmolive | 9M FY2025 net sales $3.42bn (+1.0%); FY2025 net sales +2.9%, organic +1.2%; Q1 2026 net sales $1.2bn; Q4 2025 operating profit $286m at ~24% of segment sales | Science- and vet-led premium; exited private-label pet food in 2025; acquired Prime100 in Feb 2025. High margin, low growth — the opposite profile to Freshpet |
General Mills — North America Pet (Blue Buffalo) | General Mills, Inc. | FY2026 (ended 31 May 2026) net sales $2,613.3m, +6% reported but -3% organic with organic volume -5pts; FY2025 $2,470.8m; Q1 FY2026 segment operating profit $113m | Explicitly now includes "fresh foods" in its stated product categories; acquired Whitebridge Pet Brands. A named fresh entrant cited by analysts in 2026 |
J.M. Smucker | J.M. Smucker Company | Pet segment revenue not verified | Owns Milk-Bone and Meow Mix; acquired Big Heart Pet from Del Monte in 2015; CEO detailed a pet acceleration strategy at CAGNY in February 2026 |
Post Holdings | Post Holdings, Inc. | Pet food platform revenue not verified | Value-tier pet food roll-up (Rachael Ray Nutrish, 9Lives, Kibbles 'n Bits, Nature's Recipe, Gravy Train); competes for the trade-down consumer |
The Farmer's Dog | Private | Revenue not disclosed | The most credible fresh-native competitor; DTC subscription, vet-recommended formulations; consistently ranked the most widely vet-recommended fresh brand. Competes for the premium fresh household, not the grocery shopper |
Ollie | Private (acquired by a third party in H1 2026) | Revenue not disclosed | Former Freshpet minority investee, now fully exited; DTC personalisation and picky-eater positioning; new ownership may bring scale capital |
JustFoodForDogs | Private | Revenue not disclosed | Human-grade, USDA-inspected, feeding-trial certified, vet-support prescription lines; preferred by veterinary nutritionists for research depth |
Chewy | Chewy, Inc. (NYSE: CHWY) | Revenue not verified in this review | Launched fresh dog food; controls a dominant online pet channel and the customer relationship. Analysts have explicitly cited Chewy fresh as a competitive pressure |
Costco (Kirkland Signature) | Costco Wholesale | n/a | Simultaneously Freshpet's second-largest customer (10% of net sales) and a private-label threat; analysts specifically flagged Costco fresh entry in 2026 |
Stella & Chewy's (FreshMade); Open Farm; Spot & Tango; A Pup Above; PetPlate; Primal; Raised Right | Private | Revenue not disclosed | The long tail of fresh, frozen and raw brands competing for pet specialty and natural-channel shelf |
Retailer private label | Various | n/a | Structural margin threat; the 10-K explicitly flags a shift of shelf space to private label as a risk |
| Metric | Freshpet FY2025 | Hill's Pet Nutrition (Colgate) FY2025 | General Mills North America Pet FY2026 | Nestlé Purina / Mars Petcare |
|---|---|---|---|---|
Segment net sales (USD M) | 1102.0 | nd | 2613.3 | nd |
Net sales growth, reported (%) | 13.0 | 2.9 | 6.0 | nd |
Net sales growth, organic (%) | 13.0 | 1.2 | -3.0 | nd |
Volume growth (%) | 12.0 | -1.7 | -5.0 | nd |
Segment operating margin (%) | 6.9 | nd | nd | nd |
Adjusted EBITDA margin (%) | 17.8 | nd | nd | nd |
R&D intensity (% of sales) | nd | nd | nd | nd |
Capital intensity, capex as % of sales (%) | 13.4 | nd | nd | nd |
Recent Developments
--



